Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy

Karthik Rajasekaran, Chengsan Sun, Edward H. Bertram

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The mediodorsal (MD) and paraventricular (PV) thalamic nuclei play a significant role in limbic epilepsy, and previous reports have shown changes in GABA-A receptor (GABAAR) mediated synaptic function. In this study, we examined changes in the pharmacology of GABAergic drugs and the expression of the GABAAR subunits in the MD and PV neurons in epilepsy. We observed nucleus specific changes in the sensitivity of sIPSCs to zolpidem and phenobarbital in MD and PV neurons from epileptic animals. In contrast, the magnitude of change in electrically evoked response (eIPSC) to zolpidem and phenobarbital were uniformly diminished in both MD and PV neurons in epilepsy. Immunohistochemical studies revealed that in epilepsy, there was a reduction in GAD65 expression and NeuN positive neurons in the MD neurons. Also, there was a decrease in immunoreactivity of the α1 and β2/3 subunit of GABAARs, but not the γ2 of the GABAAR in both MD and PV in epilepsy. These findings demonstrate significant alterations in the pharmacology of GABA and GABAARs in a key region for seizure generation, which may have implications for the physiology and pharmacology of limbic epilepsy.

Original languageEnglish (US)
Pages (from-to)119-132
Number of pages14
JournalNeurobiology of Disease
Volume33
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

GABA-A Receptors
Epilepsy
Pharmacology
Neurons
Phenobarbital
Midline Thalamic Nuclei
Mediodorsal Thalamic Nucleus
gamma-Aminobutyric Acid
Seizures
Pharmaceutical Preparations

Keywords

  • GABA-A receptor
  • Mediodorsal thalamus
  • Paraventricular thalamus
  • Phenobarbital
  • Temporal lobe epilepsy
  • Zolpidem

ASJC Scopus subject areas

  • Neurology

Cite this

Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy. / Rajasekaran, Karthik; Sun, Chengsan; Bertram, Edward H.

In: Neurobiology of Disease, Vol. 33, No. 1, 01.2009, p. 119-132.

Research output: Contribution to journalArticle

Rajasekaran, Karthik ; Sun, Chengsan ; Bertram, Edward H. / Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy. In: Neurobiology of Disease. 2009 ; Vol. 33, No. 1. pp. 119-132.
@article{266e23d3e39b4f75b25aff6aee58c078,
title = "Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy",
abstract = "The mediodorsal (MD) and paraventricular (PV) thalamic nuclei play a significant role in limbic epilepsy, and previous reports have shown changes in GABA-A receptor (GABAAR) mediated synaptic function. In this study, we examined changes in the pharmacology of GABAergic drugs and the expression of the GABAAR subunits in the MD and PV neurons in epilepsy. We observed nucleus specific changes in the sensitivity of sIPSCs to zolpidem and phenobarbital in MD and PV neurons from epileptic animals. In contrast, the magnitude of change in electrically evoked response (eIPSC) to zolpidem and phenobarbital were uniformly diminished in both MD and PV neurons in epilepsy. Immunohistochemical studies revealed that in epilepsy, there was a reduction in GAD65 expression and NeuN positive neurons in the MD neurons. Also, there was a decrease in immunoreactivity of the α1 and β2/3 subunit of GABAARs, but not the γ2 of the GABAAR in both MD and PV in epilepsy. These findings demonstrate significant alterations in the pharmacology of GABA and GABAARs in a key region for seizure generation, which may have implications for the physiology and pharmacology of limbic epilepsy.",
keywords = "GABA-A receptor, Mediodorsal thalamus, Paraventricular thalamus, Phenobarbital, Temporal lobe epilepsy, Zolpidem",
author = "Karthik Rajasekaran and Chengsan Sun and Bertram, {Edward H.}",
year = "2009",
month = "1",
doi = "10.1016/j.nbd.2008.09.023",
language = "English (US)",
volume = "33",
pages = "119--132",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy

AU - Rajasekaran, Karthik

AU - Sun, Chengsan

AU - Bertram, Edward H.

PY - 2009/1

Y1 - 2009/1

N2 - The mediodorsal (MD) and paraventricular (PV) thalamic nuclei play a significant role in limbic epilepsy, and previous reports have shown changes in GABA-A receptor (GABAAR) mediated synaptic function. In this study, we examined changes in the pharmacology of GABAergic drugs and the expression of the GABAAR subunits in the MD and PV neurons in epilepsy. We observed nucleus specific changes in the sensitivity of sIPSCs to zolpidem and phenobarbital in MD and PV neurons from epileptic animals. In contrast, the magnitude of change in electrically evoked response (eIPSC) to zolpidem and phenobarbital were uniformly diminished in both MD and PV neurons in epilepsy. Immunohistochemical studies revealed that in epilepsy, there was a reduction in GAD65 expression and NeuN positive neurons in the MD neurons. Also, there was a decrease in immunoreactivity of the α1 and β2/3 subunit of GABAARs, but not the γ2 of the GABAAR in both MD and PV in epilepsy. These findings demonstrate significant alterations in the pharmacology of GABA and GABAARs in a key region for seizure generation, which may have implications for the physiology and pharmacology of limbic epilepsy.

AB - The mediodorsal (MD) and paraventricular (PV) thalamic nuclei play a significant role in limbic epilepsy, and previous reports have shown changes in GABA-A receptor (GABAAR) mediated synaptic function. In this study, we examined changes in the pharmacology of GABAergic drugs and the expression of the GABAAR subunits in the MD and PV neurons in epilepsy. We observed nucleus specific changes in the sensitivity of sIPSCs to zolpidem and phenobarbital in MD and PV neurons from epileptic animals. In contrast, the magnitude of change in electrically evoked response (eIPSC) to zolpidem and phenobarbital were uniformly diminished in both MD and PV neurons in epilepsy. Immunohistochemical studies revealed that in epilepsy, there was a reduction in GAD65 expression and NeuN positive neurons in the MD neurons. Also, there was a decrease in immunoreactivity of the α1 and β2/3 subunit of GABAARs, but not the γ2 of the GABAAR in both MD and PV in epilepsy. These findings demonstrate significant alterations in the pharmacology of GABA and GABAARs in a key region for seizure generation, which may have implications for the physiology and pharmacology of limbic epilepsy.

KW - GABA-A receptor

KW - Mediodorsal thalamus

KW - Paraventricular thalamus

KW - Phenobarbital

KW - Temporal lobe epilepsy

KW - Zolpidem

UR - http://www.scopus.com/inward/record.url?scp=57449109489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57449109489&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2008.09.023

DO - 10.1016/j.nbd.2008.09.023

M3 - Article

VL - 33

SP - 119

EP - 132

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 1

ER -